According to the latest research by Future Market Insights, the Fish-Oil Based Drugs Market will witness growth during 2021-2031 with a CAGR of 8.4%. With current researches paving the path for further in depth study which will give minimum discomfort to the victims of this disorder are a positive sign for the faecal extraction systems market.
With increase in prevalence of inflammatory bowel syndromes and cancer, this market will receive boost due to scientist’s willingness to find new ways to treat diseases in the forecast period to the global market.
What is Driving Demand for Fish-Oil Based Drugs Market?
Oils extracted from fish is rich in Omega-3 fatty acids known as Eicosapentaenoic Acid (EPA), Docosahexaenoic acid (DHA). It is also known to refrain the blood from clotting easily. These compounds help in reducing pain and inflammation caused to the human body, making these healing property of fish-oil a major driver in this market.
Furthermore, the mentioned healing properties result into its application into treatment and management of various diseases like coronary heart disease (CHD), Raynaud’s Syndrome, etc. This ability to help in treating diseases across diverse verticals of ailments is another important driver for this drug market.
Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14041
When any kind of inflammation occurs in the human body, some inflammatory bio-markers like calprotectin congregate at the site. Inflammation is a common occurrence in rheumatoid arthritis. Therefore, a June 2021 study published in the Nutrition Journal of Science Direct evaluated the effects of Fish Oil along with Cranberry juice in patients suffering from rheumatoid arthritis. This at the end proved to be beneficial for the patients as the inflammation as well as the inflammatory biomarkers were decreased after consuming this combinations.
Fish-oil in treatment of Neuro-degenerative Diseases –
An intriguing study was published in Springer (26 March 2020) which studied role of fish-oil along with butter-oil against Oxidative stress. These two oils were used in combination with an anti-Alzheimer drug known as galantamine hydrobromide.
Aim was to study was discover its role in improving brain permeation and providing neural protection against oxidative stress. The results showed the when co-administered, FO and BO enhanced the permeation level of the brain but also improved drug delivery across the blood brain barrier which can further help in treatment of any neurodegenerative diseases that cause oxidative stress.
U.S. and Canada Fish-Oil Based Drugs Market –
According to Centre for Disease Control, 1 person dies every 36 seconds due to some kind of cardiovascular condition in the US. Also, CDC projected that by 2025, 67 million Americans will get affected by arthritis in a year. Fish-oil plays an important treatment of these diseases.
Recently, at the end of 2019, FDA approved a drug which is based on fish-oil as a preventive medicine of heart attack and stroke. Icosapent ethyl is a purified form of EPA was officially approved by USFDA.
Developments like these will aid U.S in dominating the market as the increase in importance of detection, prevention and treatment of any disease will further boost this market.
Europe Fish-Oil Based Drugs Market –
European region is close to America in fish-oil based drugs market. Statistics given by European Brain Council say that 1 in 8 European is affected by some kind of neural system disease. Owing to the recent researches and to the facts mentioned above, fish-oil based drugs are sure to experience a good boost in Europe. Key European players include BASF SE, GC Rieber Oil, etc.
Who are the key manufacturing and supplying companies in Fish-Oil Based Drugs Market?
- Solutex GC
- Aker Biomarine
- Croda International PLC
- Stepan Company
- Pharma Marine
- GC Rieber Oil
- Clover Corporation
- BASF SE
- Omega Protein Corporation
- United Laboratories
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Fish-Oil Based Drugs Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.
For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14041
Key Segments –
By Source type:
By Form type:
- Eicosapentaenoic Acid (EPA)
- Docosahexaenoic acid (DHA)
- Coronary Heart Disease (CHD)
- Rheumatoid Arthritis
- Raynaud’s Syndrome
By Distribution Channel:
- Supermarkets/ Hypermarkets/Food Stores
- Drug Stores & Pharmacies
- Online Retailers
- North America
- Latin America
- South Asia
- East Asia
- Middle East & Africa